Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01588470Phase 4Completed
A Phase 4 trial of pioglitazone in type 2 diabetes mellitus (T2DM), coronary heart disease (CHD), sponsored by UT Health San Antonio. Started Jun 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01588470.